Sangamo Therapeutics, Inc (SGMO) — DEF 14A Filings
All DEF 14A filings from Sangamo Therapeutics, Inc. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Sangamo Therapeutics Executive Compensation Details
— Apr 30, 2025 Risk: low
Sangamo Therapeutics, Inc. filed its DEF 14A on April 30, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includ -
Sangamo Therapeutics Sets June 4th Virtual Annual Meeting
— Apr 19, 2024 Risk: low
Sangamo Therapeutics, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, at 8:30 a.m. Pacific Time. The primary purpose is to ele
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX